about
Aerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesImmunological and histopathological changes in the atrial tissue during and after cardiopulmonary bypassCarvedilol in the treatment of chronic heart failure.Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver diseaseEffect of exercise training on interleukin-6, tumour necrosis factor alpha and functional capacity in heart failureSystemic consequences of ventricular assist devices: alterations of coagulation, immune function, inflammation, and the neuroendocrine system.PKCβII inhibition attenuates myocardial infarction induced heart failure and is associated with a reduction of fibrosis and pro-inflammatory responsesModification of a volume-overload heart failure model to track myocardial remodeling and device-related reverse remodeling.IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart.The effect of physical training on systemic proinflammatory cytokine expression in heart failure patients: a systematic review.Cardiac dysfunction in cirrhosis - does adrenal function play a role? A hypothesis.Correlation of serum biomarkers in adults with single ventricles with strain and strain rate using 2D speckle tracking.Experimental Evidences Supporting the Benefits of Exercise Training in Heart Failure.Anti-inflammatory effect of cardiac resynchronization therapy.
P2860
Q26767412-20DEF453-701E-46D3-B6DC-ADDF9BF9DE09Q33807897-D9976D41-499F-4EE7-B569-766BF649E742Q34241046-6B984A29-5090-45E8-A484-BF97F8C229F6Q34467402-22AE53F6-4360-4D80-A057-59E1B83D8FB1Q34635227-957BE168-6CB4-47D1-9AC6-F339E102E1A4Q34983349-1847CC97-2AD9-4EB8-AA30-3D9AB3FA9090Q35106609-8BF1549F-1399-4C18-98EA-8524892E6AC2Q35684279-504FE3B3-F9DE-4B83-AA29-D5B9D77846CBQ37200229-40C6D602-AD63-4B0D-828A-9E68BE657DCBQ37879224-517A263F-9847-435F-A642-437BE1CAABDAQ37980263-EDC24AAC-14F6-48CD-9EC5-B7C83B921FBFQ39535023-1388F088-C317-48FB-B209-7D7E307356B8Q48023234-5D94A6C5-8898-44F5-9A42-65990DB9E984Q48456795-71FEB250-31D7-44EE-AD2D-110665EC7870
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Inflammatory mediators in heart failure.
@ast
Inflammatory mediators in heart failure.
@en
type
label
Inflammatory mediators in heart failure.
@ast
Inflammatory mediators in heart failure.
@en
prefLabel
Inflammatory mediators in heart failure.
@ast
Inflammatory mediators in heart failure.
@en
P1476
Inflammatory mediators in heart failure.
@en
P2093
Niebauer J
P304
P356
10.1016/S0167-5273(99)00190-4
P577
2000-02-01T00:00:00Z